Noxopharm Ltd. NOX

ASX · Australia · Health Technology

AUD 0.05900.00 (0.00%)

Market open· Sep 30, 2026, 2:48 AM UTC· AUD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Noxopharm Ltd. NOX

ASX · Australia · Health Technology

AUD 0.05900.00 (0.00%)

Market open· Sep 30, 2026, 2:48 AM UTC· AUD · Data may be delayed

-1.67% · 6MFull-screen chart

Open AUD 0.0590High AUD 0.0590Low AUD 0.0590Close AUD 0.0590Volume 0

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: AUD 0.0590
Day range: AUD 0.0590 – AUD 0.0600
52-week range: AUD 0.0510 – AUD 0.1100
Volume: 10.64K
Market cap: AUD 18.13M
Avg. volume (1Y): 125.73K

Performance

1 week

-6.35%

1 month

-33.71%

3 months

-35.87%

6 months

-1.67%

Year to date

-37.23%

1 year

-34.44%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Australia
Exchange: ASX
Shares outstanding: 307.24M
ISIN: AU000000NOX9
Beta: 0.26

Technical view

Details →

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Details →

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

Prices may be delayed and are for informational purposes only - not investment advice.

-1.67% · 6MFull-screen chart

Open AUD 0.0590High AUD 0.0590Low AUD 0.0590Close AUD 0.0590Volume 0

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: AUD 0.0590
Day range: AUD 0.0590 – AUD 0.0600
52-week range: AUD 0.0510 – AUD 0.1100
Volume: 10.64K
Market cap: AUD 18.13M
Avg. volume (1Y): 125.73K

Performance

1 week

-6.35%

1 month

-33.71%

3 months

-35.87%

6 months

-1.67%

Year to date

-37.23%

1 year

-34.44%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Australia
Exchange: ASX
Shares outstanding: 307.24M
ISIN: AU000000NOX9
Beta: 0.26

Technical view

Details →

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Details →

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.